1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Alleviate TNBS-Induced Colitis and Exhibit No Significant Testicular Toxicity
Pharmaceuticals · 08.04.2025 · 18 (4) · 546
DOI: 10.3390/ph18040546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 08.04.2025. Verfasst von Anna Merwid-Ląd und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Wroclaw Medical University, Mikulicza-Radeckiego 2, 50-345 Wrocław, Poland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Background/Objectives: Inflammatory bowel disease significantly impairs the patient’s quality of life. In young individuals, both the disease and the drugs used for the treatment may impact fertility. Our study aimed to assess the action of new 1,3,4-oxadiazole derivatives of pyrrolo[3,4-d]pyridazinone on the rat testes in a model of TNBS-induced colitis in rats.
Methods
In the current study, testes from eight randomly chosen rats were taken from each of the following groups: the control group (K), the colitis group (C), and the groups receiving compounds 7b, 10b, and 13b in higher doses (20 mg/kg).
Results
Colitis did not affect the testicular index (expressed as a percentage of the body weight), but in group 13b, this parameter was significantly higher than in group K. No significant differences between groups were noticed in malondialdehyde, superoxide dismutase, interleukin-1, or metalloproteinase 9 levels. In the colitis group, lactate dehydrogenase activity in the testes was not increased; however, the administration of compound 10b significantly increased this parameter when compared to both groups K and C. Histological evaluation also did not reveal abnormalities, and the morphology of the testicular tissues was comparable in all groups.
Conclusions
The results may suggest that the new 1,3,4-oxadiazole derivatives of pyrrolo[3,4-d]pyridazinone did not exert significant testicular toxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Wroclaw Medical University, Mikulicza-Radeckiego 2, 50-345 Wrocław, Poland.
- Department of Clinical and Experimental Pathology, Wroclaw Medical University, Marcinkowskiego 1, 50-368 Wrocław, Poland.
- Department of Medicinal Chemistry, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland.
ORCID-Profile: Anna Merwid-Ląd, Beata Nowak, Piotr Świątek, Łukasz Szczukowski, Marta Szandruk-Bender
Förderung
- Wroclaw Medical University
Zitieren
APA
Merwid-Ląd, A., Ziółkowski, P., Nowak, B., Świątek, P., Szczukowski, Ł., Kwiatkowska, J., Piasecka, K., Szeląg, A., & Szandruk-Bender, M. (2025). 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Alleviate TNBS-Induced Colitis and Exhibit No Significant Testicular Toxicity. Pharmaceuticals, 18(4), 546. https://doi.org/10.3390/ph18040546
Vancouver
Merwid-Ląd A, Ziółkowski P, Nowak B, Świątek P, Szczukowski Ł, Kwiatkowska J, et al. 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Alleviate TNBS-Induced Colitis and Exhibit No Significant Testicular Toxicity. Pharmaceuticals. 2025;18(4):546. doi:10.3390/ph18040546
BibTeX
@article{MerwidLd2025,
author = {Merwid-Ląd, Anna and Ziółkowski, Piotr and Nowak, Beata and Świątek, Piotr and Szczukowski, Łukasz and Kwiatkowska, Joanna and Piasecka, Katarzyna and Szeląg, Adam and Szandruk-Bender, Marta},
title = {1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Alleviate TNBS-Induced Colitis and Exhibit No Significant Testicular Toxicity},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {4},
pages = {546},
doi = {10.3390/ph18040546}
}
EUVIMED